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Abstract
Objective: S100A4 can bind to p53 in vitro. However, it is unclear whether the proteins interact in
the nuclei of living cells.
Methods: Initially, using an optical biosensor, the ability of CFP-S100A4 to bindwith p53-YFPwas
examined in vitro. The fluorescence resonance energy transfer (FRET) technique using laser con-
focal microscopy was applied to detect the interaction of S100A4with p53 in living cells.
Results: Imaging FRET in HeLa cells expressing S100A4 and p53 showed an increase in cyan
fluorescent protein fluorescence intensity, after photobleaching yellow fluorescent protein in
cell nuclei. In comparison, the imaging of cell nuclei expressing mutant S100A4-C and p53 or
S100A4 and yellow fluorescent protein as the negative control showed the occurrence of FRET,
and demonstrated that the interaction between S100A4 and p53 occurred in the nuclei of living
HeLa cells. However, FRET did not occur in the cytoplasm of cells, showing that S100A4 did not
interact with p53 in the cytoplasm.
Conclusion: S100A4 can interact directly with p53 in the nuclei of living cells. This might be a
molecular basis for metastasis-inducing S100A4 in vivo. The results also suggest that the inhibi-
tion of the calcium-binding site of S100A4might be a possible anticancer therapy.
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1 INTRODUCTION
S100A4 is a member of the S100 family of Ca2+-binding proteins, a
polypeptide of 101 amino acids, andhas amolecularmass of∼11.5 kd.1
The expression of this protein is significantly associatedwith a reduced
survival rate for patients with cancers.2–5 Experiments with different
transgenic mice or rats models have provided evidence of the effect of
S100A4-induced tumormetastasis.6-9 S100A4 is therefore a potential
target for antimetastatic therapy.10–12
S100A4 protein has been reported to interact in a calcium-
dependent manner with multiple molecular target proteins, such as
the heavy chain of non-muscle myosin, liprin1, and p53 in vitro, all of
whichmight be involved in itsmetastasis-inducing abilities.13 Although
we have found that the C-terminal end of S100A4 plays a key role
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in the interaction with the heavy chain of non-muscle myosin and
the metastasis-inducing tumor in vitro and in vivo, the mechanism of
metastasis inductionbyS100A4 in vivo remains unknown.12,14 S100A4
has been reported to show a Ca2+-dependent interaction with p53
in vitro.15 Although S100A4 was shown to be colocalized with p53 in
individual cancer cell nuclei, there is no direct evidence to confirm the
interaction of S100A4with p53 in living cell nuclei.16
The interaction of S100A4 with p53 in living HeLa cells has now
been investigated using confocal microscopy and the fluorescence
resonance energy transfer (FRET) technique. FRET, the non-radiative
transfer of photon energy from an excited fluorophore (donor) to a
neighboring fluorophore (acceptor), occurs only when the donor and
acceptor are in close proximity (<100 A). This approach can be used
tomeasure nanometer scale distances, and has made it possible to use
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this technique to detect protein–protein interactions in the nuclei of
living cells.2,17
The aim of the present studywas to find outwhether S100A4 inter-
actswith p53 in the nuclei of living cells, and thereby acts as a potential
therapeutic strategy.
2 METHODS
2.1 Plasmids
Living Colors plasmid vectors pEYFP and pECFP were obtained from
Clontech (Palo Alto, CA, USA). The amplified, recombinant, full-length
human p53 mRNA was cloned between the HindIII and BamHI sites
of a Living Color EYFP vector, such that a fusion protein, consisting
of enhanced yellow fluorescent protein (EYFP) attached to p53 (p53-
YFP), was encoded. The construction of pCFP-S100A4 plasmids, con-
taining S100A4 cDNA, was as previously described.14
2.2 Production of recombinant fusion proteins in
Escherichia coli
The coding sequences of CFP-S100A4, CFP-S100A4-C, p53-YFPwere
excised from the Living Color expression vectors and were inserted
into an engineered pET16 vector between an NheI site (inserted
adjacent to the existing NdeI site) and a BamHI site, as previously
described.14 The open reading frames of the fusion proteins were con-
firmed through automated DNA sequencing. Recombinant fusion pro-
teins were expressed in the E. coli strain, BL21-DE3, and purified using
HisBind Resin (Novagen, Madison,WI, USA).
2.3 Target binding by CFP-S100A4 and p53-YFP
To assess either S100A4 or mutant S100A4-C and p53 interaction
in vitro, the interactions between the CFP-S100A4s fusion proteins
and the p53-YFP fusion protein were determined using a dual-channel
IAsys resonant mirror biosensor (Thermo Electron, Basingstoke, UK),
as described previously.14
2.4 Cell culture and transfection
HeLa cervical carcinoma cells were grown and transfected, as
described previously.14
2.5 Fluorescencemicroscopy and FRET analysis
HeLa cells (3× 105) were transiently transfectedwith plasmids encod-
ing CFP-S100A4, CFP-S100A4-C, and p53-YFP using FuGene (Roche,
Basel, Switzerland). Fluorescencewas visualizedusing a confocal laser-
scanning microscope (Zeiss-LSM-510 META; Carl Zeiss, Oberkochen,
Germany). Cyan fluorescent protein (CFP) fluorescence was excited at
458nmand signalswere detected,with theMETAdetector set at 490–
520 nm. YFP fluorescencewas achieved at an excitation of 514 nm and
detected at 559–615 nm. For the acquisition of FRET signals, CFP was
excited with a laser, set to 458 nm, and FRET signals were detected in
the YFP channel of the META detector set to 559–615 nm. Protein
interactions were further confirmed by acceptor photobleaching.18
Cells were treated by scanning a region of interest 100 times, using a
laser set to 514 nm (YFP settings) at 100% intensity. Before and after
treatment, CFP imageswere collected tomonitor changes in donor flu-
orescence. Based on this procedure, FRET efficiencywas calculated by
photobleaching of the acceptor (YFP), resulting in an increase in donor
fluorescence (CFP). The average intensity of CFP fluorescence, for five
points’ time after and before photobleaching YFP, was analyzed.
3 RESULTS
3.1 Identification of S100A4 interacting with p53
in vitro using an optical biosensor
To examine the effect of wild-type S100A4 binding to p53, an optical
biosensor was used to detect their interaction in vitro. The recombi-
nant p53-YFP was immobilized onto the amino silane surface of the
biosensor cuvette. As the mS100A4-C, a variant S100A4 protein from
another study,12 has lost the functions of wild-type S100A4 described
previously, it was used as a negative control. CFP-S100A4 and CFP-
mS100A4-C, at different concentrations, were added individually
to the p53-YFP surface in the presence of 0.5 mM calcium iron. The
results show that the extent of wild-type S100A4 binding to p53 is
significantly higher than that of variantmS100A4-C (Figure 1a,b), indi-
cating that wild-type S100A4 can interact with p53 in vitro. However,
mS100A4-C showed a virtually undetectable interaction with p53
in vitro (P< 0.0001, Student's test; Figure 1a,b).
3.2 Imaging FRET by photobleaching YFP
fluorescence in cells transfectedwith CFP-S100A4 and
p53-YFP
To testwhether S100A4directly associateswithp53 in living cells, cells
(Figure 2) co-transfected with CFP-S100A4 and p53-YFP cDNA were
detected by measuring the intensity of CFP fluorescence before and
after photobleaching YFP fluorescence, using FRET imaging through
laser confocal microscopy. The results showed that the CFP fluores-
cence intensity in the cell nuclei (red cycle) increased after photo-
bleaching YFP fluorescence (top, post-), when compared with that
before photobleaching YFP fluorescence (top, pre-; Figure 2a). This
increase indicated the occurrence of FRET, and showed that the inter-
action between S100A4 and p53 occurred in living HeLa cells. How-
ever, no increase in CFP fluorescence intensity in the cell cytoplasm
(yellow cycle) was observed after photobleaching of YFP fluorescence
(Figure 2b), suggesting that FRET did not occur in the cytoplasm.
Therefore, S100A4 did not interact with p53 in the cytoplasm of cells
co-transfected with CFP-S100A4 and p53-YFP. These observations
were further verified using six HeLa cells (Figure 3a,b).
Due to the loss in the ability of mS100A4-C to bind its target
proteins, such as NMMHCIIA, in vitro and in vivo,12,14 and p53, in vitro
(Figure 1), transfected cells (Figure 4), expressing bothCFP-mS100A4-
C and p53-YFP proteins, were also examined by measuring CFP
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F IGURE 1 Interaction of wild-type S100A4
with immobilized p53 using an optical biosensor.
The extents of binding of wild-type S100A4
(S100A4) andmutant S100A4-C (mS100A4-C) to
immobilized p53weremeasured using an optical
biosensor. Purified p53-YFPwas immobilized on a
planar amino silane surface. After the addition of
CFP-S100A4 and S100A4-C-YFP in two
biosensor cuvettes, respectively, the extents of
binding of the S100A4swere followed in real-time
for at least, 5 min. Data were collected every 0.3 s
during the course of the experiment and analyzed
using FastFit software (n= 3 for each bar)
F IGURE 2 Cyan fluorescent protein (CFP),
fluorescence resonance energy transfer (FRET),
and yellow fluorescent protein (YFP) images taken
before and after photobleaching in HeLa cells
co-transfected with CFP-S100A4 and p53-YFP. A
HeLa cell transiently co-transfected with the
CFP-S100A4 and p53-YFP cDNA construct was
illuminated with a Zeiss two-photon laser and
examined 18–24 h after transfection by Zeiss
confocal microscopy. Two regions of interest (red
and yellow cycles) were analyzed for CFP
fluorescence intensity after (post-) and before
(pre-) photobleaching of YFP. The photobleaching
image of YFP fluorescence in the cell is shown in
the lower panels (YFP), CFP fluorescence in the
upper panels (CFP), and total fluorescence
intensity distributions in themiddle panels (FRET).
(a,b) Changes in CFP and YFP fluorescence
intensities of two regions of interest are shown.
Changes in CFP and YFP fluorescence intensities
before and after photobleaching YFP in the (a) cell
nucleus and (b) cytoplasm. The locations of upward
and downward arrows indicate the beginning and
end of photobleaching of YFP, respectively
fluorescence intensity after photobleaching YFP fluorescence. As a
negative control, the results, as expected, showed a decrease in CFP
fluorescence intensity in the cell nuclei (red cycle, pre/post-, Figure 4a)
and cytoplasm (yellow cycle, pre/post, Figure 4B) after photobleaching
YFP fluorescence, compared with that before photobleaching YFP
fluorescence.
Data from nine HeLa cells (Figure 5) showed no significant changes
in themeanCFP fluorescence intensities between pre-photobleaching
YFP and post-photobleaching YFP in the nuclei (Figure 5a,b) or cyto-
plasms (Figure 5c,d) of cells co-transfected with CFP-S100A4-C and
p53-YFP cDNA. This suggests a lack of occurrence of both FRET and
the interaction between the mutant S100A4-C and p53 molecules in
the nuclei and cytoplasms of living HeLa cells co-expressing the CFP-
S100A4-C and p53-YFP proteins.
Using the same approach for FRET signal acquisition and analysis,
the interactions betweenCFP-S100A4 and YFP, CFP and p53-YFP, and
the paralleling negative controls were examined separately. Cells co-
transfected with CFP-S100A4 and YFP, and CFP and p53-YFP, like the
paralleling negative control cells co-transfectedwithCFP-mS100A4-C
and p53-YFP, showed decreases in CFP fluorescence intensities after
photobleaching YFP fluorescence in the nuclei and cytoplasm (data
not shown), indicating the absence of FRET, and lack of interactions
between CFP-S100A4 and YFP, and CFP and p53-YFP in transfected
living cells.
4 DISCUSSION
FRET-based techniques provide a way of studying the interaction
betweenproteins in vivo, andarepotentially useful for studyingprotein
interaction dynamics as well.14,19 In the present study, we confirmed
that neither S100A4 nor CFP-S100A4 interacted with YFP in vitro and
in vivo, as described previously,14 and verified that the fusion of the flu-
orescent proteins did not affect the ability of either S100A4 or its tar-
get proteins to interact. Simultaneously, the negative control, variant
S100A4-C, was used alongside the experimental samples so as tomon-
itor false positives.
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F IGURE 3 Changes in cyan fluorescent protein (CFP) fluorescence intensities after photobleaching yellow fluorescent protein (YFP)
fluorescence in the nuclei and cytoplasm of HeLa cells co-transfected with CFP-S100A4 and p53-YFP. FRET in six HeLa cells expressing
CFP-S100A4 and p53-YFPwas examined by calculating themean intensity of CFP fluorescence before/after photobleaching YFP fluorescence.
Donor (CFP) fluorescence in the presence of acceptor (YFP) fluorescence (Da); that is, before the photobleaching of YFP fluorescence. Donor
(CFP) fluorescence in the absence of acceptor (YFP) fluorescence (D); that is, after the photobleaching of YFP fluorescence. (a,b) Themean
intensity (pixels) of CFP fluorescence after photobleaching YFP fluorescence (D) in the nuclei of six HeLa cells co-transfected with CFP-S100A4
and p53-YFP cDNA increased comparedwith that before photobleaching YFP fluorescence (Da), indicating FRET occurrence (in the nucleus). (c,d)
Themean intensity (pixels) of CFP fluorescence after photobleaching YFP fluorescence (D) in the cytoplasm of theHeLa cells decreased compared
with that before photobleaching YFP fluorescence (Da), indicating the absence of FRET (in the cytoplasm). Total n= 6 cells for each bar, three
experiments
F IGURE 4 Cyan fluorescent protein (CFP),
fluorescence resonance energy transfer (FRET),
and yellow fluorescent protein (YFP) images
taken before and after photobleaching YFP in
HeLa cells co-transfected with
CFP-mS100A4-C and p53-YFP. Two regions of
interest (red cycle for nucleus and yellow cycle
for cytoplasm) of HeLa cells transiently
co-transfected with CFP-mS100A4-C and
p53-YFP cDNA constructs were analyzed for
CFP fluorescence intensity after (post-) and
before (pre-) photobleaching YFP fluorescence.
The photobleaching image of YFP fluorescence
in one cell is shown in the lower panels (YFP),
CFP fluorescence in the upper panels (CFP), and
the total fluorescence intensity distributions in
themiddle panels (FRET). Changes in CFP and
YFP fluorescence intensities before and after
photobleaching YFP in the (a) cell nucleus and
(b) cytoplasm. The locations of upward and
downward arrows indicate the beginning and
end of photobleaching, respectively
LIU ET AL. 27
F IGURE 5 Fluorescence resonance energy
transfer (FRET) in the nucleus and cytoplasm of
HeLa cells co-transfected with CFP-S100A4-C
and p53-YFP cDNA. FRET in nine HeLa cells
expressing CFP-S100A4-C and p53-YFPwas
analyzed by calculating themean intensity of
cyan fluorescent protein (CFP) fluorescence
before/after photobleaching yellow fluorescent
protein (YFP) fluorescence. Donor (CFP)
fluorescence in the presence of acceptor (YFP)
fluorescence (Da); that is, before the
photobleaching of YFP fluorescence. Donor
(CFP) fluorescence in the absence of acceptor
(YFP) fluorescence (D); that is, after the
photobleaching of YFP fluorescence. (a,b) The
mean intensity of (b) CFP fluorescence
decreased after photobleaching YFP
fluorescence (D) in the nucleus of nine HeLa
cells co-transfected with CFP-S100A4-C and
p53-YFP cDNA, indicating the absence of FRET
in the nucleus. (c,d) Similarly, themean intensity
(pixels) of (d) CFP fluorescence decreased after
photobleaching YFP fluorescence (D) compared
with that before photobleaching YFP
fluorescence (Da) in the cytoplasm of HeLa cells;
that is, no FRET occurred in the cytoplasm. Total
n= 9 cells for each bar, three experiments
FRET data from HeLa cells co-transfected with CFP-S100A4s
and p53-YFP were first collected and analyzed. These showed an
active functional interaction between the S100A4 and p53 proteins
(Figures 2a, 3a,b), and the co-localization of this interaction in the
nuclei (Figure 2a, 3a,b), but not in the cytoplasm (Figure 2b, 3c/d) of
living HeLa cells. However, no FRET occurred between the mS100A4-
C (inactivated calcium binding site) and p53 (Figure 5a–d), confirming
that themutant S100A4-Ccertainly lost the ability to interactwithp53
in vivo.
Indeed, these might be expected, because the results are com-
pletely consistent with in vitro studies. In detecting the ability of wild-
type and mutant S100A4 to bind to p53 in vitro, using an optical
biosensor (Figure 1), wild-type S100A4 proteins showed strong abil-
ities to bind to p53. However, interaction between mutant S100A4-
C and p53 was undetectable. Interestingly, the effects of S100A4
interaction with p53 in vitro and in vivo show similar effects to that
of S100A4 with rNMMHCIIA in vitro and in vivo,14 respectively.20–22
Conversely, the co-localizations of their interactions in living cells are
different.16 Immunofluorescent staining of cultured mammary tumor
S100A4 cells localized much of the S100A4 protein in the perinu-
clear cytoskeleton. The same trend of co-localization of interactions of
S100A4 with rNMMHCIIA was observed in the FLIM study.14 It was
reported that p53 can physiologically rapidly import into the nucleus
and also export,23 and can be excluded from the nucleus during DNA
synthesis.24 However, thepresentdata showed that the co-localization
of interactions of S100A4with p53 is inside the nuclei ofHela cells.We
observed that p53-YFP fused proteins begin to migrate from the cyto-
plasm to the nucleus 1.5 h after co-transfection of p53-YFP and CFP-
S100A4, and then accumulate in the nucleus, and do not move out of
the nucleus until observation time, 4 h later. This finding is coinciden-
tally consistent with a report that showed that S100A4 can regulate
the subcellular localization of p53 by disrupting the tetramerization of
p53 when S100A4 binds to its tetramerization domain.25 Therefore,
we propose that S100A4 might interact with the C-terminus of the
p53 molecule in the nucleus, induce conformational changes in p53,
and then modulate functional activities of p53. This is because the
C-terminus of the p53 molecule is responsible for activities, such as
oligomerization, nuclear translocation, binding to damaged DNA, reg-
ulating specific DNA binding activity in the core domain, and modulat-
ing p53 transcriptional activity, which likely take place in the nucleus.15
This further strongly indicates that nuclear co-localization is most
likely important for the interaction of S100A4with p53 in living cells.
Elevated S100A4 levels in tumormetastasis suggest a role in tumor
progression.2,26 As S100A4 itself is unable to initiate tumors, it was
proposed that it might act in cooperation with other oncogenes.27
p53 prevents tumorigenic transformation through the induction of cell
cycle arrest or apoptosis.25 S100A4 expression was inversely associ-
ated with elevated levels of wild-type p53.2,27 and implied that the
physical interaction between wild-type p53 and S100A4 might result
in a stimulation of cell entry into the S phase.15
In conclusion, the S100A4 protein, but not the variant S100A4-C
protein with a mutation in the C EF-hand domain (control), can inter-
act directly with p53 in the cell nucleus. The pattern of interactions
between S100A4 and p53, as indicated by FRET images, coincideswith
the pattern of S100A4 binding to immobilized p53 in vitro in optical
biosensor studies. This suggests that the interaction of S100A4 and
p53 occurs in the nuclei of living HeLa cells, which might be a molec-
ular basis formetastasis induction by S100A4. The present results also
suggest that the inhibition of the calcium-binding site in the C EF-hand
of S100A4might be a possible anticancer therapy.
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